{"meta":{"humanUrl":"https://us-uk.bookimed.com/clinics/country=china/illness=immunotherapy/best/","canonicalUrl":"https://us-uk.bookimed.com/clinics/country=china/illness=immunotherapy/best/","jsonUrl":"https://us-uk.bookimed.com/clinics/country=china/illness=immunotherapy/best/data.json","title":"Best clinics for Immunotherapy in China — Ratings & Reviews | Bookimed","description":"5 top-rated clinics for Immunotherapy in China. Compare rankings, prices, and patient reviews on Bookimed.","heading":"Best clinics for Immunotherapy in China","locale":"en","schemaVersion":"ClinicBestPageDataV1","snapshotId":"241eb5da-a93afc36","contentVersion":"241eb5da","generatedAt":"2026-11-13T17:11:35.667Z"},"filters":{"country":"china","illness":"immunotherapy","page":1},"pagination":{"page":1,"totalCount":5,"totalPages":1},"breadcrumbs":[{"name":"Home","url":"/"},{"name":"Clinics","url":"/clinics/"},{"name":"China","url":"/clinics/country=china/"},{"name":"Immunotherapy","url":"/clinics/country=china/illness=immunotherapy/"},{"name":"Best","url":"/clinics/country=china/illness=immunotherapy/best/"}],"entities":[{"name":"China","alias":"china","type":"country","id":203},{"name":"Immunotherapy","alias":"immunotherapy","type":"illness","id":3568}],"clinics":{"clinics":[{"text":"<p>Xiamen Humanity Hospital serves as the first BNCT center in mainland China, offering precision oncology with 4th generation Da Vinci systems. The oncology department integrates immunotherapy with radiotherapy and targeted treatments. Diagnostics start with a treatment plan consultation for around $30 or a neurosurgeon visit for about $50. A biochemical blood analysis costs around $100, while PET-CT imaging runs $130–$200. The hospital provides multilingual support and concierge services to assist international patients during their care.</p>","text_type":"mt_wow_description","best_texts":{"techniques":"Immunotherapy","good_fit_for":"Patients interested in clinical trial immunotherapy","why_its_ranked":"Integrated immunotherapy with chemo, radio, targeted therapy, and support. On-site PET-CT and a Phase I trial ward enable precise staging and trial access."},"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}],"reviews":[],"clinic":{"id":7249,"alias":"xiamen-humanity-hospital","name":"Xiamen Humanity Hospital","short_description":"<p><strong>Xiamen Humanity Hospital</strong> is a private multi-specialty medical center located in Xiamen, China, specializing in neurosurgery, orthopedics, oncology, and ophthalmology. It is a tertiary, not-for-profit general hospital with over 47 clinical and technical departments, 1,000 inpatient beds, and a total area of 330,000 m². The hospital is accredited to conduct Phase I–IV drug trials, as well as clinical trials for medical devices and IVD products. Xiamen Humanity Hospital serves both adults and children, treating around 1,000,000 patients annually, with patients from CIS countries, Europe &amp; Commonwealth, and Asia visiting most often.</p>\n","images":[{"base_url":"clinic/6968b23686aee","title":"Xiamen Humanity Hospital modern clinic building exterior in Xiamen, China"},{"base_url":"clinic/6968b24813c1a","title":"Reception area at Xiamen Humanity Hospital with modern seating and glass partition"},{"base_url":"clinic/6968b25235577","title":"Spacious modern atrium at Xiamen Humanity Hospital with glass ceiling in China"},{"base_url":"clinic/6968b26e1acd9","title":"Reception area at Xiamen Humanity Hospital International Medical Center, modern design"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Xiamen","id":2685,"alias":"xiamen"},"address":"3777 Xianyue Rd, Hu Li Qu, Xia Men Shi, Fujian, China, 361016"},"rating":{"rating":4.7,"google":3.5,"percent_of_satisfied_clients":98},"statistics":{"number_of_reviews":3,"doctors_number":460,"year_foundation":2018},"accreditations":[],"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}]}},{"text":"<p>Dr. Luo Jiamin focuses on combining immunotherapy with interventional techniques for advanced tumors at this 400-bed facility. The hospital uses a multidisciplinary team to create personalized plans integrating immune checkpoint inhibitors with ablation or radiotherapy. Online consultations start around $150, while a whole-body CT or PET/CT scan costs around $1,300. Treatment includes a consultation with the MDT team and a tailored therapy strategy. The center features specialized technologies like NanoKnife and cryoablation for minimally invasive care.</p>","text_type":"mt_wow_description","best_texts":{"techniques":"Immunotherapy, targeted therapy, chemotherapy, minimally invasive interventional therapy, ablation, cryoablation","good_fit_for":"Advanced or recurrent solid tumors needing combination immunotherapy","why_its_ranked":"Immune checkpoint inhibitors combined with interventional techniques. Multidisciplinary team integrates immunotherapy with cryoablation, NanoKnife, TACE. Doctors trained at Johns Hopkins."},"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}],"reviews":[],"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[],"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}]}},{"text":"<p>Sun Yat-sen University Cancer Center (SYSUCC) is a university hospital in Guangzhou, China. It is one of the country's largest integrated cancer centers. The center treats adults and children across 35 clinical departments. Major specialties include medical oncology, radiation oncology, and neurosurgery. The neurosurgery team performs about 1,400 procedures each year.</p><p>The center opened in 1964 as a specialized tumor hospital. In 2023, it managed over 1.84 million outpatient visits. Surgeons performed more than 45,000 operations that same year. SYSUCC runs two campuses with 2,247 ward beds and 42 operating rooms. It has been a UICC member since 2012.</p><p>The hospital uses four da Vinci robots for minimally invasive surgery. Other technologies include CyberKnife and proton-beam therapy. SYSUCC was among the first Chinese hospitals to adopt digital pathology. It also has a dedicated radionuclide production and nuclear medicine unit. International patients get support through a specialized International Medical Center.</p>","text_type":"short_description","reviews":[],"clinic":{"id":8343,"alias":"sun-yat-sen-university-cancer-center-sysucc","name":"Sun Yat-sen University Cancer Center (SYSUCC)","short_description":"<p>Sun Yat-sen University Cancer Center (SYSUCC) is a university hospital in Guangzhou, China. It is one of the country's largest integrated cancer centers. The center treats adults and children across 35 clinical departments. Major specialties include medical oncology, radiation oncology, and neurosurgery. The neurosurgery team performs about 1,400 procedures each year.</p><p>The center opened in 1964 as a specialized tumor hospital. In 2023, it managed over 1.84 million outpatient visits. Surgeons performed more than 45,000 operations that same year. SYSUCC runs two campuses with 2,247 ward beds and 42 operating rooms. It has been a UICC member since 2012.</p><p>The hospital uses four da Vinci robots for minimally invasive surgery. Other technologies include CyberKnife and proton-beam therapy. SYSUCC was among the first Chinese hospitals to adopt digital pathology. It also has a dedicated radionuclide production and nuclear medicine unit. International patients get support through a specialized International Medical Center.</p>","images":[{"base_url":"clinic/6a6cf96aee095","title":"Modern clinic building of Sun Yat-sen University Cancer Center in Guangzhou, China"},{"base_url":"clinic/6a6cf96c5f042","title":"Reception desk at Sun Yat-sen University Cancer Center, modern hospital interior"},{"base_url":"clinic/6a6cf96dbe79d","title":"Dental treatment room with modern equipment at Sun Yat-sen University Cancer Center"},{"base_url":"clinic/6a6cf96f2e6c0","title":"Sun Yat-sen University Cancer Center exterior in Guangzhou, China"}],"flags":[{"name":"is_hide","value":false},{"name":"is_created_by_parser","value":true}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Guangzhou","id":390,"alias":"guangzhou"},"address":"651 Dongfeng East Road, Yuexiu District, Guangzhou 510060, P. R. China"},"rating":{"rating":0,"google":4,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":91,"year_foundation":1964},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d1129badf6c5.jpeg","name":"European Society for Medical Oncology","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5cfa0ad8c533a.jpeg","name":"Joint Commission International ","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d88caba297f8.jpeg","name":"Fellow, American College of Surgeons","country_code":"US"}]}},{"text":"<p>Beijing Puhua International Hospital runs a multidisciplinary IVIG program coordinated by neurologists and nutritionists. Before treatment, the team uses lymphocyte subset testing and cytokine profiling. Clinical assessment guides an individualized plan, with ongoing review included. Testing and treatment prices are not listed. Flights, accommodation, and travel insurance are excluded. International patient support includes visa invitation letters, airport transfers, interpreters, and follow-up after returning home.</p>","text_type":"mt_wow_description","best_texts":{"techniques":"IVIG, traditional Chinese medicine modulation, sensory integration and rehabilitation training, multidisciplinary team approach, immune-related testing","good_fit_for":"Children with autism receiving IVIG immune modulation","why_its_ranked":"IVIG immune modulation with lymphocyte subset testing and cytokine profiling before treatment. Neurologists and nutritionists coordinate each plan."},"reviews":[],"clinic":{"id":8874,"alias":"beijing-puhua-international-hospital","name":"Beijing Puhua International Hospital","short_description":"<p>Beijing Puhua International Hospital is a multi-specialty medical center in Beijing, China. It focuses on neurology, neurosurgery, orthopedics, and rehabilitation. The hospital treats both adults and children. Pediatric services include minimally invasive brain surgery for cerebral palsy. The medical team has 111 doctors, and the hospital holds 600 beds.</p><p>The Smart Digital Orthopedics Center uses the Medtronic AiBLE navigation system for spinal care. Surgeons perform robot-assisted spine surgery and stereotactic brain procedures. Other options include Focused Ultrasound (MRgFUS) for non-surgical treatment. The hospital also runs a fecal microbiota transplantation (FMT) program with AI-assisted donor matching.</p><p>International patients get visa help, airport transfers, and interpreters. Follow-up care continues after patients return home, with records sent to local doctors.</p>","images":[{"base_url":"clinic/6adadec2a4839","title":"Modern exterior of Beijing Puhua International Hospital in Beijing, China"},{"base_url":"clinic/6adadec48bbe9","title":"Beijing Puhua International Hospital modern clinic building exterior in Beijing, China"},{"base_url":"clinic/6adadec66944a","title":"Reception and waiting area at Beijing Puhua International Hospital, modern design"},{"base_url":"clinic/6adadec7c3002","title":"Reception and waiting area at Beijing Puhua International Hospital, modern design"}],"flags":[{"name":"has_active_agencies","value":false},{"name":"is_hide","value":false},{"name":"is_created_by_parser","value":true}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Beijing","id":360,"alias":"beijing"}},"rating":{"rating":0,"google":3.8,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":1500,"year_foundation":1992},"accreditations":[]}}],"meta":{"total_count":5,"total_pages":1}},"clinicsMeta":{"total_count":5,"total_pages":1},"clinicsCount":5,"clinicsCountByEntity":{"clinic_count":24},"doctors":{"doctors":[{"doctor":{"id":11994,"alias":"liu-shi-xin","name":"Liu Shi Xin","clinic_id":7249,"photo":"doctor/6a02f359a4904","first_year_working":1986,"created_at":"2026-05-12T09:31:01.701+00:00","short_description":"<p>Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.</p><ul><li>Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.</li><li>Former President of Jilin Provincial Cancer Hospital.</li><li>Awarded the National Famous Doctor honor for outstanding contributions to oncology.</li><li>Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.</li></ul>","specialities":[{"id":"onc.006","name":"Oncologist/mammologist","illness_kind_id":10},{"id":"sur.007","name":"Surgical oncologist","illness_kind_id":33}],"statistics":{"review_count":0,"review_score":0}},"clinic":{"id":7249,"alias":"xiamen-humanity-hospital","name":"Xiamen Humanity Hospital","short_description":"<p><strong>Xiamen Humanity Hospital</strong> is a private multi-specialty medical center located in Xiamen, China, specializing in neurosurgery, orthopedics, oncology, and ophthalmology. It is a tertiary, not-for-profit general hospital with over 47 clinical and technical departments, 1,000 inpatient beds, and a total area of 330,000 m². The hospital is accredited to conduct Phase I–IV drug trials, as well as clinical trials for medical devices and IVD products. Xiamen Humanity Hospital serves both adults and children, treating around 1,000,000 patients annually, with patients from CIS countries, Europe &amp; Commonwealth, and Asia visiting most often.</p>\n","images":[{"base_url":"clinic/6968b23686aee","title":"Xiamen Humanity Hospital modern clinic building exterior in Xiamen, China"},{"base_url":"clinic/6968b24813c1a","title":"Reception area at Xiamen Humanity Hospital with modern seating and glass partition"},{"base_url":"clinic/6968b25235577","title":"Spacious modern atrium at Xiamen Humanity Hospital with glass ceiling in China"},{"base_url":"clinic/6968b26e1acd9","title":"Reception area at Xiamen Humanity Hospital International Medical Center, modern design"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Xiamen","id":2685,"alias":"xiamen"},"address":"3777 Xianyue Rd, Hu Li Qu, Xia Men Shi, Fujian, China, 361016"},"rating":{"rating":4.7,"google":3.5,"percent_of_satisfied_clients":98},"statistics":{"number_of_reviews":3,"doctors_number":460,"year_foundation":2018},"accreditations":[]}},{"doctor":{"id":13907,"alias":"liao-zhengyin","name":"Liao Zhengyin","clinic_id":8327,"photo":"doctor/6a697a03af34c","first_year_working":1991,"created_at":"2026-07-29T03:56:48.904+00:00","short_description":"<p>Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.</p>\n<p>Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.</p>\n<p>Leads 2 provincial S&amp;T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":100000}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"images":[{"image_url":"https://s3.eu-central-1.amazonaws.com/bookimed/operations_images/6a884f6aaffb0.jpeg","seo_alt":"Before and after facial tumor removal surgery results – significant improvement in lower face"},{"image_url":"https://s3.eu-central-1.amazonaws.com/bookimed/operations_images/6a8850cf29f88.jpeg","seo_alt":"Before and after AVM embolization results – reduced lip swelling and improved appearance"},{"image_url":"https://s3.eu-central-1.amazonaws.com/bookimed/operations_images/6a88511d09d31.jpeg","seo_alt":"Before and after AVM embolization results, ear and cheek vascular malformation treatment"},{"image_url":"https://s3.eu-central-1.amazonaws.com/bookimed/operations_images/6a8850281ae9c.jpeg","seo_alt":"Before and after AVM embolization results – reduced lip swelling and improved appearance"}]},{"doctor":{"id":13921,"alias":"zhang-jinshan","name":"Zhang Jinshan","clinic_id":8327,"photo":"doctor/6a69babae5863","first_year_working":1985,"created_at":"2026-07-29T08:32:55.580+00:00","description":"<p>Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.</p><p style=\"margin-left:0px;\">1980–1985: Completed doctoral studies at Nagasaki University, Japan</p><p style=\"margin-left:0px;\">1968–present: Department of Radiology, Chinese PLA General Hospital</p><p style=\"margin-left:0px;\">1988: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1989–present: Member of Radiological Society of North America(RSNA)</p><p style=\"margin-left:0px;\">1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA</p><p style=\"margin-left:0px;\">1991: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology</p><p style=\"margin-left:0px;\">1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology</p><p style=\"margin-left:0px;\">1993: Granted the Lifetime Special Government Allowance of the State Council</p><p style=\"margin-left:0px;\">1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology</p><p style=\"margin-left:0px;\">1994: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1997: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1997–2009: Standing Member of Chinese Society of Radiology</p><p style=\"margin-left:0px;\">1999: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology</p><p style=\"margin-left:0px;\">2002: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">2005: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">Member of Radiological Society of North America(RSNA)</p><p style=\"margin-left:0px;\">Standing Member of Chinese Society of Radiology</p><p style=\"margin-left:0px;\">Group Leader of the Group of Intervention of Chinese Journal of Radiology</p><p style=\"margin-left:0px;\">Deputy Director Member of Chinese Society of Interventional Oncology</p><p style=\"margin-left:0px;\">Director Member of Beijing Medical Association Society of Interventional Radiology</p><p style=\"margin-left:0px;\">Deputy Chief Editor of Chinese Journal of Medical Image Technology</p><p style=\"margin-left:0px;\">Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army</p><p style=\"margin-left:0px;\">Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology</p><p style=\"margin-left:0px;\">Awarded the Special Government Allowance of the State Council</p><p style=\"margin-left:0px;\">Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.</p><p style=\"margin-left:0px;\">Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”</p><p style=\"margin-left:0px;\">Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.</p><p style=\"margin-left:0px;text-align:justify;\">In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3o2my-3d1951d6.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3rdgs-a13c877f.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3rsxb-30a7dc56.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3s6j1-ffdc9bd7.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion\". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.</p><h3 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan’s Academic Achievements</strong></h3><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.</p><h4 style=\"margin-left:0px;\"><strong>Selected Publications by Professor Zhang Jinshan</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1. <strong>Zhang Jinshan, Wang Maoqiang. </strong><i><strong>Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology</strong></i><strong>, 1993，27（6）：361-365.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.</strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 1996，30（8）：521-524.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. He innovatively proposed the technique of \"transcatheter arterial embolization with temporary hepatic vein occlusion.\" Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>3. Zhang Jinshan, Wang Maoqiang, Li Huai. </strong>Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, <strong>1998，14（3）：189-191.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. </strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 2000，34（5）：335-337.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.</strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 2002，36（7）：612-614.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. </strong>Chinese Journal of Medical Imaging Technology, <strong>2004，20（9）：1395-1397.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. </strong><i><strong>Chinese Journal of Radiology, </strong></i><strong>2006，40（8）：876-878.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.</p><h4 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan co-authored monographs</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.</p><p style=\"margin-left:0px;text-align:justify;\">2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.</p><h4 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan’s Research project</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1.The National \"Eighth Five-Year Plan\" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">2.The Military \"Ninth Five-Year Plan\" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.</p><p style=\"margin-left:0px;text-align:justify;\">3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":50000}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]}},{"doctor":{"id":13922,"alias":"xiao-yueyong","name":"Xiao Yueyong","clinic_id":8327,"photo":"doctor/6a69c01738e84","first_year_working":1991,"created_at":"2026-07-29T08:55:44.300+00:00","short_description":"<p>Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).</p>\n<p>He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.</p>\n<p>Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]}},{"doctor":{"id":14048,"alias":"binkui-li","name":"Binkui Li","clinic_id":8343,"first_year_working":0,"created_at":"2026-07-31T19:45:21.372+00:00","short_description":"Binkui Li is a specialist at Sun Yat-sen University Cancer Center, serving as Professor, PhD supervisor, and Director of Liver Surgery. He treats liver cancers with a multidisciplinary program that combines surgery, vascular interventional therapy, targeted therapy, and immunotherapy. A key differentiator is his conversion-therapy approach for advanced liver cancer to make surgery possible when it initially isn’t.","specialities":[{"id":"sur.019","name":"Hepatobiliary surgeon","illness_kind_id":33},{"id":"sur.006","name":"Colorectal surgeon","illness_kind_id":33},{"id":"rdl.002","name":"Interventional radiologist","illness_kind_id":10}],"statistics":{"review_count":0,"review_score":0,"operations_performed_count":0,"awards_count":0}},"clinic":{"id":8343,"alias":"sun-yat-sen-university-cancer-center-sysucc","name":"Sun Yat-sen University Cancer Center (SYSUCC)","short_description":"<p>Sun Yat-sen University Cancer Center (SYSUCC) is a university hospital in Guangzhou, China. It is one of the country's largest integrated cancer centers. The center treats adults and children across 35 clinical departments. Major specialties include medical oncology, radiation oncology, and neurosurgery. The neurosurgery team performs about 1,400 procedures each year.</p><p>The center opened in 1964 as a specialized tumor hospital. In 2023, it managed over 1.84 million outpatient visits. Surgeons performed more than 45,000 operations that same year. SYSUCC runs two campuses with 2,247 ward beds and 42 operating rooms. It has been a UICC member since 2012.</p><p>The hospital uses four da Vinci robots for minimally invasive surgery. Other technologies include CyberKnife and proton-beam therapy. SYSUCC was among the first Chinese hospitals to adopt digital pathology. It also has a dedicated radionuclide production and nuclear medicine unit. International patients get support through a specialized International Medical Center.</p>","images":[{"base_url":"clinic/6a6cf96aee095","title":"Modern clinic building of Sun Yat-sen University Cancer Center in Guangzhou, China"},{"base_url":"clinic/6a6cf96c5f042","title":"Reception desk at Sun Yat-sen University Cancer Center, modern hospital interior"},{"base_url":"clinic/6a6cf96dbe79d","title":"Dental treatment room with modern equipment at Sun Yat-sen University Cancer Center"},{"base_url":"clinic/6a6cf96f2e6c0","title":"Sun Yat-sen University Cancer Center exterior in Guangzhou, China"}],"flags":[{"name":"is_hide","value":false},{"name":"is_created_by_parser","value":true}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Guangzhou","id":390,"alias":"guangzhou"},"address":"651 Dongfeng East Road, Yuexiu District, Guangzhou 510060, P. R. China"},"rating":{"rating":0,"google":4,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":91,"year_foundation":1964},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d1129badf6c5.jpeg","name":"European Society for Medical Oncology","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5cfa0ad8c533a.jpeg","name":"Joint Commission International ","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d88caba297f8.jpeg","name":"Fellow, American College of Surgeons","country_code":"US"}]}},{"doctor":{"id":14051,"alias":"desheng-weng","name":"Desheng Weng","clinic_id":8343,"first_year_working":0,"created_at":"2026-07-31T19:45:24.758+00:00","short_description":"Desheng Weng is a specialist at Sun Yat-sen University Cancer Center, where he is an Associate Professor and Deputy Director in the Biotherapy Center / Melanoma and Sarcoma Medical Oncology. He combines cancer genetics research with immunotherapy-focused oncology care. His research includes studying tumor suppressor genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 and their links to clinical features in hepatocellular carcinoma and gastric cancer.","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10}],"statistics":{"review_count":0,"review_score":0,"operations_performed_count":0,"awards_count":0}},"clinic":{"id":8343,"alias":"sun-yat-sen-university-cancer-center-sysucc","name":"Sun Yat-sen University Cancer Center (SYSUCC)","short_description":"<p>Sun Yat-sen University Cancer Center (SYSUCC) is a university hospital in Guangzhou, China. It is one of the country's largest integrated cancer centers. The center treats adults and children across 35 clinical departments. Major specialties include medical oncology, radiation oncology, and neurosurgery. The neurosurgery team performs about 1,400 procedures each year.</p><p>The center opened in 1964 as a specialized tumor hospital. In 2023, it managed over 1.84 million outpatient visits. Surgeons performed more than 45,000 operations that same year. SYSUCC runs two campuses with 2,247 ward beds and 42 operating rooms. It has been a UICC member since 2012.</p><p>The hospital uses four da Vinci robots for minimally invasive surgery. Other technologies include CyberKnife and proton-beam therapy. SYSUCC was among the first Chinese hospitals to adopt digital pathology. It also has a dedicated radionuclide production and nuclear medicine unit. International patients get support through a specialized International Medical Center.</p>","images":[{"base_url":"clinic/6a6cf96aee095","title":"Modern clinic building of Sun Yat-sen University Cancer Center in Guangzhou, China"},{"base_url":"clinic/6a6cf96c5f042","title":"Reception desk at Sun Yat-sen University Cancer Center, modern hospital interior"},{"base_url":"clinic/6a6cf96dbe79d","title":"Dental treatment room with modern equipment at Sun Yat-sen University Cancer Center"},{"base_url":"clinic/6a6cf96f2e6c0","title":"Sun Yat-sen University Cancer Center exterior in Guangzhou, China"}],"flags":[{"name":"is_hide","value":false},{"name":"is_created_by_parser","value":true}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Guangzhou","id":390,"alias":"guangzhou"},"address":"651 Dongfeng East Road, Yuexiu District, Guangzhou 510060, P. R. China"},"rating":{"rating":0,"google":4,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":91,"year_foundation":1964},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d1129badf6c5.jpeg","name":"European Society for Medical Oncology","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5cfa0ad8c533a.jpeg","name":"Joint Commission International ","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d88caba297f8.jpeg","name":"Fellow, American College of Surgeons","country_code":"US"}]}},{"doctor":{"id":14054,"alias":"jianchuan-xia","name":"Jianchuan Xia","clinic_id":8343,"first_year_working":0,"created_at":"2026-07-31T19:45:28.045+00:00","short_description":"Jianchuan Xia is a specialist at Sun Yat-sen University Cancer Center, where he works as Professor in the Biotherapy Center / Melanoma and Sarcoma Medical Oncology. He combines cancer genetics research with immunotherapy-focused oncology care. His genetics work includes studying tumor suppressor genes such as ING2, TESTIN, BATF2, LZAP, and BIN1 in hepatocellular carcinoma and gastric cancer.","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"imm.002","name":"Immunologist","illness_kind_id":21}],"statistics":{"review_count":0,"review_score":0,"operations_performed_count":0,"awards_count":0}},"clinic":{"id":8343,"alias":"sun-yat-sen-university-cancer-center-sysucc","name":"Sun Yat-sen University Cancer Center (SYSUCC)","short_description":"<p>Sun Yat-sen University Cancer Center (SYSUCC) is a university hospital in Guangzhou, China. It is one of the country's largest integrated cancer centers. The center treats adults and children across 35 clinical departments. Major specialties include medical oncology, radiation oncology, and neurosurgery. The neurosurgery team performs about 1,400 procedures each year.</p><p>The center opened in 1964 as a specialized tumor hospital. In 2023, it managed over 1.84 million outpatient visits. Surgeons performed more than 45,000 operations that same year. SYSUCC runs two campuses with 2,247 ward beds and 42 operating rooms. It has been a UICC member since 2012.</p><p>The hospital uses four da Vinci robots for minimally invasive surgery. Other technologies include CyberKnife and proton-beam therapy. SYSUCC was among the first Chinese hospitals to adopt digital pathology. It also has a dedicated radionuclide production and nuclear medicine unit. International patients get support through a specialized International Medical Center.</p>","images":[{"base_url":"clinic/6a6cf96aee095","title":"Modern clinic building of Sun Yat-sen University Cancer Center in Guangzhou, China"},{"base_url":"clinic/6a6cf96c5f042","title":"Reception desk at Sun Yat-sen University Cancer Center, modern hospital interior"},{"base_url":"clinic/6a6cf96dbe79d","title":"Dental treatment room with modern equipment at Sun Yat-sen University Cancer Center"},{"base_url":"clinic/6a6cf96f2e6c0","title":"Sun Yat-sen University Cancer Center exterior in Guangzhou, China"}],"flags":[{"name":"is_hide","value":false},{"name":"is_created_by_parser","value":true}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Guangzhou","id":390,"alias":"guangzhou"},"address":"651 Dongfeng East Road, Yuexiu District, Guangzhou 510060, P. R. China"},"rating":{"rating":0,"google":4,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":91,"year_foundation":1964},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d1129badf6c5.jpeg","name":"European Society for Medical Oncology","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5cfa0ad8c533a.jpeg","name":"Joint Commission International ","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5d88caba297f8.jpeg","name":"Fellow, American College of Surgeons","country_code":"US"}]}}],"meta":{"total_count":7,"total_pages":1}},"offers":{"cards":[],"metadata":{"total_count":0}},"listingTexts":{"entity_texts":{},"texts":{}},"relations":{"countries":[{"name":"China","alias":"china","iso_code":"CN"},{"name":"Dominican Republic","alias":"dominican-republic","iso_code":"DO"},{"name":"Egypt","alias":"egypt","iso_code":"EG"},{"name":"Israel","alias":"israel","iso_code":"IL"},{"name":"Latvia","alias":"latvia","iso_code":"LV"},{"name":"Mexico","alias":"mexico","iso_code":"MX"},{"name":"Republic of Korea","alias":"republic-of-korea","iso_code":"KR"},{"name":"Spain","alias":"spain","iso_code":"ES"},{"name":"Thailand","alias":"thailand","iso_code":"TH"},{"name":"Turkey","alias":"turkey","iso_code":"TR"}],"cities":[{"name":"Beijing","alias":"beijing"},{"name":"Guangzhou","alias":"guangzhou"},{"name":"Chengdu","alias":"chengdu"},{"name":"Xiamen","alias":"xiamen"}],"operations":[{"name":"Brain tumor surgery","alias":"brain-tumor-surgery"},{"name":"CyberKnife for brain tumor","alias":"cyberknife-for-brain-tumor"},{"name":"High intensity focused ultrasound ablation (HIFU)","alias":"high-intensity-focused-ultrasound-ablation-hifu"},{"name":"Craniotomy","alias":"craniotomy"},{"name":"Transnasal resection of tumor","alias":"transnasal-resection-of-tumor"},{"name":"Radiosurgery of a brain tumor","alias":"radiosurgery-of-a-brain-tumor"},{"name":"Resection of glioma","alias":"resection-of-glioma"},{"name":"Resection of glioblastoma","alias":"resection-of-glioblastoma"},{"name":"Removal of spinal cord tumor","alias":"removal-of-spinal-cord-tumor"},{"name":"Chemotherapy for breast cancer","alias":"chemotherapy-for-breast-cancer"},{"name":"Chemotherapy","alias":"chemotherapy"},{"name":"Lymphoma chemotherapy","alias":"lymphoma-chemotherapy"},{"name":"Immunotherapy","alias":"immunotherapy"},{"name":"Immunotherapy for breast cancer","alias":"immunotherapy-for-breast-cancer"},{"name":"Brain tumor removal","alias":"removal-of-the-brain-tumor"},{"name":"Brachytherapy","alias":"brachytherapy"},{"name":"Radiotherapy","alias":"radiotherapy"},{"name":"Stereotaxic radiosurgery","alias":"stereotaxic-surgery"},{"name":"Chemotherapy for larynx cancer","alias":"chemotherapy-for-larynx-cancer"},{"name":"Chemotherapy for lung cancer","alias":"chemotherapy-for-lung-cancer"},{"name":"Chemotherapy for prostate cancer","alias":"chemotherapy-for-prostate-cancer"},{"name":"Chemotherapy for uterine cancer","alias":"chemotherapy-for-uterine-cancer"},{"name":"Chemotherapy for pancreatic cancer","alias":"chemotherapy-for-pancreatic-cancer"},{"name":"Gamma-knife for spinal tumor","alias":"gamma-knife-for-spinal-tumor"},{"name":"Radiation therapy for  Brain Tumor","alias":"radiation-therapy-for-brain-cancer"},{"name":"Cryotherapy for kidney cancer","alias":"cryotherapy-for-kidney-cancer"},{"name":"Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","alias":"hyperthermic-intraperitoneal-chemotherapy"},{"name":"Mastectomy","alias":"mastectomy"},{"name":"Proton-beam therapy","alias":"proton-beam-therapy"},{"name":"Omentectomy ","alias":"omentectomy"},{"name":"Removal of colon cancer","alias":"removal-of-colon-cancer"},{"name":"Removal of liver cancer","alias":"removal-of-liver-cancer"},{"name":"Distal Pancreatectomy","alias":"distal-pancreatectomy"},{"name":"Removal of meningioma","alias":"removal-of-meningioma"},{"name":"Excision of skull base tumor","alias":"excision-of-skull-base-tumor"},{"name":"Radiation therapy for colorectal cancer","alias":"radiation-therapy-for-colorectal-cancer"},{"name":"Radiation therapy for brain tumor","alias":"radiation-therapy-for-brain-tumor"},{"name":"Chemotherapy for liver cancer","alias":"chemotherapy-for-liver-cancer"},{"name":"Chemoembolization of the liver","alias":"chemoembolization-of-the-liver"},{"name":"Throat cancer operation","alias":"throat-cancer-operation"},{"name":"Gastroectomy","alias":"gastroectomy"},{"name":"Radiofrequency ablation","alias":"radiofrequency-ablation"},{"name":"Targeted therapy","alias":"targeted-therapy"},{"name":"HIFU for prostate cancer treatment","alias":"hifu-for-prostate-cancer-treatment"},{"name":"NanoKnife","alias":"nanoknife"},{"name":"Brachytherapy for prostate cancer","alias":"brachytherapy-for-prostate-cancer"},{"name":"Radiofrequency ablation of the liver","alias":"radiofrequency-ablation-of-the-liver"},{"name":"Radiotherapy for prostate cancer","alias":"radiotherapy-for-prostate-cancer"},{"name":"Brachytherapy for uterine cancer","alias":"brachytherapy-for-cervical-cancer"},{"name":"Radiotherapy for lung cancer","alias":"radiotherapy-for-lung-cancer"},{"name":"Brachytherapy for Breast Cancer","alias":"brachytherapy-for-breast-cancer"},{"name":" Cryotherapy","alias":"cryotherapy"},{"name":"Trachelectomy (cervicectomy)","alias":"trachelectomy-cervicectomy"}],"diagnostics":[{"name":"Consultation with a neurosurgeon","alias":"consultation-neurosurgeon"},{"name":"Revision of MRI results","alias":"revision-of-mri-results"},{"name":"Chest X-Ray","alias":"chest-x-ray"},{"name":"Consultation of a radiologist","alias":"consultation-radiologist"},{"name":"MRI of the abdominal cavity","alias":"mri-of-the-abdominal-cavity"},{"name":"CT of the chest","alias":"ct-of-the-chest"},{"name":"Thyroid ultrasound","alias":"thyroid-ultrasound"},{"name":" Scintigraphy","alias":"bone-gammagraphy"},{"name":"PET/CT in lymphoma","alias":"petct-in-lymphoma"},{"name":"Online Consultation with Hematologist","alias":"online-consultation-with-hematologist"},{"name":"PET/CT","alias":"pet-ct"},{"name":" Сomplex oncology diagnostic","alias":"somplex-oncology-diagnostic"},{"name":"MRI of one area","alias":"mri-one-department"},{"name":"CT (computer tomography)","alias":"ct"},{"name":"Gastroscopy with biopsy","alias":"gastroscopy--biopsy"},{"name":"Biopsy","alias":"biopsy"},{"name":"Extended analysis of blood","alias":"extended-analysis-of-blood"},{"name":"Biochemical blood analysis","alias":"biochemical-analysis-of-blood"},{"name":"Tumor Marker Blood Test","alias":"identification-of-tumor-markers"},{"name":" BRAF gene mutation ","alias":"braf-gene-mutation"},{"name":"Fine-needle aspiration biopsy","alias":"fine-needle-aspiration-biopsy"},{"name":" Trepanobiopsy","alias":"core-needle-biopsy"},{"name":" Frozen section biopsy","alias":"frozen-section-biopsy"},{"name":" Transrectal ultrasound (TRUS)","alias":"transrectal-ultrasound-trus"},{"name":"Cancer screening","alias":"screening-for-cancer"},{"name":"Сomprehensive diagnosis of Leukemia","alias":"somprehensive-diagnosis-of-leukemia"},{"name":"Oncological Check-up for Women","alias":"oncological-check-up-for-women"},{"name":"Oncological Check-up for Man","alias":"oncological-check-up-for-man"},{"name":"Early detection of malignant diseases for men","alias":"early-detection-of-malignant-diseases-for-men"},{"name":"Colonoscopy","alias":"colonoscopy"},{"name":"Bronchoscopy + biopsy","alias":"bronchoscopy--biopsy"},{"name":" CT of thoracic, abdominal and pelvic organs","alias":"ct-of-three-cavities"},{"name":"Comprehensive diagnosis of lymphomas","alias":"comprehensive-diagnosis-of-lymphomas"},{"name":"Comprehensive diagnosis of Сolorectal Pathology","alias":"comprehensive-diagnosis-of-solorectal-pathology"},{"name":"Scintigraphy based on somatostatine receptors","alias":"scintigraphy-based-on-somatostatine-receptors"},{"name":"PET-CT with Fluoromisonidazole (18F-FMISO PET)","alias":"pet-ct-with-fluoromisonidazole-18f-fmiso-pet"},{"name":"Complex diagnostics of esophageal cancer","alias":"complex-diagnostics-of-esophageal-cancer"},{"name":"PET-CT with Gallium 68 (DOTATATE)","alias":"pet-ct-with-gallium-68dotatate"},{"name":"Scintigraphy","alias":"scintigraphy"},{"name":"Consultation with creation of treatment plan ","alias":"consultation-with-creation-of-treatment-plan"},{"name":"PET/CT in lung cancer","alias":"petct-in-lung-cancer"},{"name":"PET/CT in breast cancer","alias":"petct-in-breast-cancer"},{"name":"Complex diagnostics of cervical cancer","alias":"complex-diagnostics-of-cervical-cancer"},{"name":"Immunohistochemistry","alias":"immunohistochemistry"},{"name":"Complex diagnosis of Pancreatic cancer","alias":"complex-diagnosis-of-pancreatic-cancer"},{"name":"Complex diagnosis of  colorectal cancer","alias":"complex-diagnosis-of-colorectal-cancer"},{"name":"PET-CT with Gallium 68 (DOTA)","alias":"pet-ct-with-gallium-68dota"},{"name":"Diagnostic Iodine-131 scanning","alias":"diagnostic-iodine-131-scanning"},{"name":"PET-CT with 18F-Sodium Fluoride (F-18 NaF PET)","alias":"pet-ct-with-18f-sodium-fluoride-f-18-naf-pet"},{"name":"PET-CT with 18F-Fluoro-Ethyl-Tyrosine (18 F-FET PET)","alias":"pet-ct-with-18f-fluoro-ethyl-tyrosine-18-f-fet-pet"},{"name":"PET-CT with 18F-dihydroxyphenylalanine (F-DOPA PET)","alias":"pet-ct-with-18f-dihydroxyphenylalanine-f-dopa-pet"},{"name":"PET-CT with Fluoroestradiol (FES PET)","alias":"pet-ct-with-fluoroestradiol-fes-pet"},{"name":"PET-CT with Sifalin-TATE","alias":"pet-ct-with-sifalin-tate"},{"name":"Online Consultation with Oncologist","alias":"online-consultation-with-oncologist"},{"name":"CT scan of the whole body","alias":"ct-scan-of-the-whole-body"},{"name":"PET-CT with Gallium 68(PSMA)","alias":"pet-ct-with-gallium-68"},{"name":"Skin biopsy","alias":"skin-biopsy"},{"name":"Brain MRI","alias":"brain-mri"},{"name":"Thyroid function tests (including T3, T4, TSH)","alias":"thyroid-function-tests-including-t3-t4-tsh"},{"name":"Consultation with an oncologist","alias":"consultation-of-oncologist"}],"illnesses":[{"name":"Immunotherapy","alias":"immunotherapy"}],"illnessKinds":[{"name":"Oncology","alias":"oncology"}],"illness_kinds":[{"name":"Oncology","alias":"oncology"}]},"popularSearches":[{"name":"Immunotherapy","alias":"immunotherapy","type":"operation","id":283},{"name":" Immunotherapy with Keytruda (Pembolizumab)","alias":"keytruda","type":"operation","id":491},{"name":"Chemotherapy","alias":"chemotherapy","type":"operation","id":37},{"name":"Bone marrow transplantation","alias":"bone-marrow-transplantation","type":"operation","id":141},{"name":"Radiofrequency ablation","alias":"radiofrequency-ablation","type":"operation","id":116},{"name":"MRI of one area","alias":"mri-one-department","type":"diagnostic","id":6},{"name":"Colonoscopy","alias":"colonoscopy","type":"diagnostic","id":9},{"name":"PET/CT","alias":"pet-ct","type":"diagnostic","id":1},{"name":"Consultation with an oncologist","alias":"consultation-of-oncologist","type":"diagnostic","id":102},{"name":"Consultation with creation of treatment plan ","alias":"consultation-with-creation-of-treatment-plan","type":"diagnostic","id":457},{"name":"Breast cancer","alias":"breast-cancer","type":"illness","id":3},{"name":"Prostate cancer","alias":"prostate-cancer","type":"illness","id":97},{"name":"Lung cancer","alias":"lung-cancer","type":"illness","id":4},{"name":"Pancreatic cancer ","alias":"pancreatic-cancer","type":"illness","id":7},{"name":"Stomach cancer","alias":"stomach-cancer","type":"illness","id":51}],"operationPrices":{"operation_prices":{}},"responsibleDoctor":{"id":290,"alias":"yesim-yildirim","name":"Yesim Yildirim","photo":"doctor/699da18e34fa6","advisory_text":"20 years of experience\nMedical oncologist, ESMO certified","linkedin":"","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10}]},"direction":{"id":10,"name":"Oncology","alias":"oncology"},"illness_kind":{"id":10,"name":{"en":"Oncology"}},"hrefLanguages":[{"rel":"alternate","hreflang":"ru","language":"ru","href":"https://ru.bookimed.com/clinics/country=kitaj/illness=immunotherapy/"}],"questionsAndAnswers":[],"seoTests":{"thin_content":false,"no_txt_after_3_clinics":false},"offerFilters":{"offer_count":0,"country_filter":[{"id":45,"name":"Thailand","alias":"thailand","iso_code":"TH"}],"price_filter":{"from":0,"to":0,"avg":0}},"leadsCount":{"leads_count":53942},"manualSeo":[],"updatedAt":null,"activeCountries":["CN","TR","AT","TH"],"hasVideoReviewsByContext":false,"hasCriticalApiFallback":false}